Soujanya Ravi
2348 posts
Why Ondas Inc.’s Rotron Aerospace acquisition could expand its footprint in NATO drone programs (NASDAQ: ONDS)
Ondas Inc. acquires Rotron Aerospace to expand long-range drone propulsion technology and defense capabilities. Discover what this means for the drone industry.
March 16, 2026
Why the IRX4204 research could reshape how the industry thinks about breast cancer prevention
Could IRX4204 prevent aggressive breast cancers? Discover why new RXR research may reshape how the biotech industry approaches cancer prevention.
March 15, 2026
The rare disease opportunity behind BridgeBio Pharma’s BBP-418 breakthrough (NASDAQ: BBIO)
BridgeBio Pharma advances BBP-418 after Phase 3 muscular dystrophy results. Could the therapy unlock a major rare disease opportunity? Read the full analysis.
March 15, 2026
Why the EMA review of PolTREG-T1D could influence autoimmune cell therapy development
PolTREG-T1D moves toward European Medicines Agency review. Discover how this TREG cell therapy could reshape treatment for autoimmune diseases.
March 14, 2026
How Kaneka Corporation’s partnership with Toro Neurovascular could reshape U.S. commercialization of neurovascular catheters
Toro Neurovascular wins FDA clearance for the Toro 88 catheter. Discover how Kaneka Corporation’s partnership could reshape the U.S. neurovascular device market.
March 14, 2026
What the LYMPHIR–pembrolizumab combination signals for the future of immunotherapy resistance (NASDAQ: CTOR)
Citius Oncology reports LYMPHIR immunotherapy data in gynecologic cancers. Discover what the trial signals for the future of cancer immunotherapy.
March 13, 2026
Can acoustic tomography compete with mammography and MRI in dense breast screening for QT Imaging Holdings Inc. (NASDAQ: QTI)?
QT Imaging Holdings Inc. wins FDA clearance for Breast Acoustic CT upgrade. Discover what it means for radiation-free breast imaging and dense breast screening.
March 13, 2026
The $9bn concussion treatment question Oragenics hopes ONP-002 can answer
Oragenics launches Phase IIa trial of ONP-002 for concussion. Discover whether this therapy could unlock the $9B traumatic brain injury market.
March 13, 2026
How the Classover Holdings Inc.–Walimaker robotics collaboration could reshape STEM learning programs (NASDAQ: KIDZ)
Classover Holdings Inc. partners with Walimaker to explore robotics education programs. Discover what this move could mean for edtech growth. Read more.
March 13, 2026
Can liquid cooling solve the power crisis in hyperscale AI data centers?
Can liquid cooling solve the growing power crisis in hyperscale AI data centers? Explore how advanced cooling technologies may reshape AI infrastructure.
March 13, 2026